Hannah Valantine Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Hannah Valantine is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 7,465 shares of BBIO, which is worth approximately $341,673. The most recent transaction as insider was on Jun 26, 2025, when has been sold 2,418 shares (Common Stock) at a price of $44.06 per share, resulting in proceeds of $106,537. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.47K

323.19% 3M change

323.19% 12M change

Total Value Held $341,673

Hannah Valantine Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 26 2025	SELL Open market or private sale	$106,537 $44.06 p/Share	2,418 Reduced 24.47%	7,465 Common Stock
Jun 20 2025	BUY Grant, award, or other acquisition	-	6,589 Added 44.1%	8,353 Common Stock
Jun 10 2025	SELL Open market or private sale	$171,680 $40.0 p/Share	4,292 Reduced 70.87%	1,764 Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	$71,891 $16.75 p/Share	4,292 Added 41.48%	6,056 Common Stock
Mar 06 2025	SELL Open market or private sale	$419,467 $32.58 p/Share	12,875 Reduced 87.95%	1,764 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	$215,656 $16.75 p/Share	12,875 Added 46.79%	14,639 Common Stock
Feb 15 2024	SELL Open market or private sale	$110,041 $37.75 p/Share	2,915 Reduced 62.3%	1,764 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	$24,631 $8.45 p/Share	2,915 Added 38.39%	4,679 Common Stock
Jan 16 2024	SELL Open market or private sale	$110,682 $37.97 p/Share	2,915 Reduced 62.3%	1,764 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	$24,631 $8.45 p/Share	2,915 Added 38.39%	4,679 Common Stock
Dec 15 2023	SELL Open market or private sale	$105,289 $36.12 p/Share	2,915 Reduced 62.3%	1,764 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$24,631 $8.45 p/Share	2,915 Added 38.39%	4,679 Common Stock
Nov 15 2023	SELL Open market or private sale	$87,450 $30.0 p/Share	2,915 Reduced 62.3%	1,764 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$24,631 $8.45 p/Share	2,915 Added 38.39%	4,679 Common Stock
Dec 29 2021	BUY Open market or private purchase	$25,102 $14.23 p/Share	1,764 Added 50.0%	1,764 Common Stock

Also insider at

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Healthcare

Director

CDNA

CareDx, Inc. Healthcare